Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

1.

The development of vaccine viruses against pandemic A(H1N1) influenza.

Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, Guilfoyle K, Roseby S, Newman R, Collin R, Wallis C, Engelhardt OG, Wood JM, Le J, Manojkumar R, Pokorny BA, Silverman J, Devis R, Bucher D, Verity E, Agius C, Camuglia S, Ong C, Rockman S, Curtis A, Schoofs P, Zoueva O, Xie H, Li X, Lin Z, Ye Z, Chen LM, O'Neill E, Balish A, Lipatov AS, Guo Z, Isakova I, Davis CT, Rivailler P, Gustin KM, Belser JA, Maines TR, Tumpey TM, Xu X, Katz JM, Klimov A, Cox NJ, Donis RO.

Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.

PMID:
21199698
[PubMed - indexed for MEDLINE]
2.

Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.

Abelin A, Colegate T, Gardner S, Hehme N, Palache A.

Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27. Review.

PMID:
21115061
[PubMed - indexed for MEDLINE]
Free Article
3.

Pandemic influenza A (H1N1) 2009 vaccine: an update.

Goel MK, Goel M, Khanna P, Mittal K.

Indian J Med Microbiol. 2011 Jan-Mar;29(1):13-8. doi: 10.4103/0255-0857.76517. Review.

PMID:
21304188
[PubMed - indexed for MEDLINE]
Free Article
4.

Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens.

Strecker T, Uhlendorff J, Diederich S, Lenz-Bauer C, Trusheim H, Roth B, Kolesnikova L, Aepinus C, Dornow R, Gerlach J, Matrosovich M, Valley U, Eickmann M, Becker S.

Clin Chem Lab Med. 2012 May 23;50(7):1275-9. doi: 10.1515/cclm-2011-0650.

PMID:
22850059
[PubMed - indexed for MEDLINE]
5.

Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.

Chao DY, Cheng KF, Hsieh YH, Li TC, Wu TN, Chen CY, Tsai CA, Chen JH, Chiu HT, Lu JJ, Su MC, Liao YH; CIDER.

Vaccine. 2011 Jan 17;29(4):617-23. doi: 10.1016/j.vaccine.2010.11.016. Epub 2010 Nov 21.

PMID:
21095255
[PubMed - indexed for MEDLINE]
6.

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.

Zhao G, Sun S, Du L, Xiao W, Ru Z, Kou Z, Guo Y, Yu H, Jiang S, Lone Y, Zheng BJ, Zhou Y.

Virol J. 2010 Jul 12;7:151. doi: 10.1186/1743-422X-7-151.

PMID:
20624292
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Protection of ferrets from infection by swine-origin 2009 A (H1N1) influenza virus by the inactivated vaccine.

Shin JS, Do Hwang S, Kim HS, Cho SW, Seo SH.

Viral Immunol. 2010 Aug;23(4):395-402. doi: 10.1089/vim.2010.0022.

PMID:
20712484
[PubMed - indexed for MEDLINE]
8.

Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.

Dikow R, Eckerle I, Ksoll-Rudek D, Hampel H, Schwenger V, Zeier M, Schnitzler P, Sommerer C.

Am J Kidney Dis. 2011 May;57(5):716-23. doi: 10.1053/j.ajkd.2010.11.031. Epub 2011 Feb 23.

PMID:
21349617
[PubMed - indexed for MEDLINE]
9.

Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.

Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.

Vaccine. 2008 Jun 2;26(23):2912-8. doi: 10.1016/j.vaccine.2008.03.048. Epub 2008 Apr 11.

PMID:
18448208
[PubMed - indexed for MEDLINE]
10.

A note on the use of influenza vaccination strategies when supply is limited.

Lee S, Morales R, Castillo-Chavez C.

Math Biosci Eng. 2011 Jan;8(1):171-82. doi: 10.3934/mbe.2011.8.171.

PMID:
21361406
[PubMed - indexed for MEDLINE]
11.

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y.

Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13.

PMID:
18336962
[PubMed - indexed for MEDLINE]
12.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
[PubMed - indexed for MEDLINE]
13.

[Pandemic influenza vaccines. How should they be designed?].

Löwer J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1238-41. doi: 10.1007/s00103-010-1159-z. German.

PMID:
21161473
[PubMed - indexed for MEDLINE]
14.

Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).

Poland GA.

Vaccine. 2011 Jan 17;29(4):613-4. doi: 10.1016/j.vaccine.2010.11.086. No abstract available.

PMID:
21193121
[PubMed - indexed for MEDLINE]
15.

Influenza vaccines: the good, the bad, and the eggs.

Schultz-Cherry S, Jones JC.

Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Review.

PMID:
20951870
[PubMed - indexed for MEDLINE]
16.

Vaccination against influenza: role and limitations in pandemic intervention plans.

Rebmann T, Zelicoff A.

Expert Rev Vaccines. 2012 Aug;11(8):1009-19. Review.

PMID:
23002981
[PubMed - indexed for MEDLINE]
17.

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

Rudenko L, van den Bosch H, Kiseleva I, Mironov A, Naikhin A, Larionova N, Bushmenkov D.

Vaccine. 2011 Jul 1;29 Suppl 1:A40-4. doi: 10.1016/j.vaccine.2011.04.122. Review.

PMID:
21684428
[PubMed - indexed for MEDLINE]
Free Article
18.

Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.

Prosper O, Saucedo O, Thompson D, Torres-Garcia G, Wang X, Castillo-Chavez C.

Math Biosci Eng. 2011 Jan;8(1):141-70. doi: 10.3934/mbe.2011.8.141.

PMID:
21361405
[PubMed - indexed for MEDLINE]
19.

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.

Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, Frimmel S, Riebold D, Reisinger EC.

Vaccine. 2011 Feb 1;29(6):1228-34. doi: 10.1016/j.vaccine.2010.11.092. Epub 2010 Dec 15.

PMID:
21167116
[PubMed - indexed for MEDLINE]
20.

Pre-pandemic and pandemic influenza vaccines.

Rockman S, Brown L.

Hum Vaccin. 2010 Oct;6(10):792-801. Epub 2010 Oct 1. Review.

PMID:
20935469
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk